Pleural Mesothelioma

Pleural mesothelioma is a form of cancer caused primarily by inhaling asbestos fibers. It develops in the pleura�the thin, double-layered lining surrounding the lungs. This aggressive cancer spreads rapidly, and an estimated 80% to 90% of all mesothelioma diagnoses are malignant pleural mesothelioma (MPM).

Pleural mesothelioma is the most common and fastest-spreading form of mesothelioma, strongly linked to long-term asbestos exposure.

What Is Pleural Mesothelioma?

Pleural mesothelioma is one of the most common forms of mesothelioma and affects the pleura, the protective lining around the lungs. It is almost always caused by asbestos exposure and is known for its aggressive progression and late detection.

Pleural Mesothelioma Facts

Common symptoms include chest pain, fatigue, dry cough, and shortness of breath. Pleural mesothelioma is not curable, but aggressive treatment can improve long-term survival. Approximately 2,500�3,000 people are diagnosed each year.

Diagnosis typically involves imaging tests such as CT scans, followed by biopsies. Treatment options include surgery, chemotherapy, immunotherapy, and radiation therapy.

Why Choose Us for Your Asbestos Exposure Claim?

Free No-Obligation Review

We provide free no-obligation A. B. Barone asbestos exposure case review

Contingency Representation

We work on a contingency basis, meaning there are no fees unless we collect for you

Expertise In Asbestos & Mesothelioma Lawsuits

We have experience winning claims against huge multi-national corporations

Symptoms of Pleural Mesothelioma

Symptoms typically appear 10 to 50 years after asbestos exposure. Early symptoms often involve the respiratory system and chest cavity, including:

? Chest pain
? Dry cough
? Fatigue
? Fever and night sweats
? Shortness of breath (dyspnea)
? Coughing up blood
? Unexplained weight loss
? Pleural effusion (fluid buildup around the lungs)

As the disease progresses, symptoms worsen. In stage IV, coughing up blood may become frequent, and swallowing may become difficult. Some patients also experience co-occurring asbestos-related conditions.

Diagnosis of Pleural Mesothelioma

Diagnosis begins with imaging tests such as X-rays and CT scans to detect tumors or signs of metastasis. If abnormalities are found, physicians may order blood tests to check for mesothelioma-related biomarkers.

A biopsy is required to confirm malignant pleural mesothelioma. Common biopsy procedures include:

Thoracentesis: A needle removes excess fluid from the chest cavity for analysis.
Thoracoscopy: A minimally invasive procedure using a thoracoscope to view the pleura and collect tissue samples.

Stages of Malignant Pleural Mesothelioma

Staging determines how far the cancer has spread and guides treatment decisions. The most widely used system is the TNM staging system:

? T (Tumor): Size and extent of the primary tumor
? N (Node): Whether cancer has spread to lymph nodes
? M (Metastasis): Whether cancer has spread to distant organs

Stages I and II typically involve limited or no metastasis. Stages III and IV indicate advanced disease with spread to lymph nodes or distant organs. Accurate staging helps physicians determine the most effective treatment plan.